1.Portal flow steal after liver transplantation.
Bohyun KIM ; Kyoung Won KIM ; Gi Won SONG ; Sung Gyu LEE
Clinical and Molecular Hepatology 2015;21(3):314-317
Portal flow steal occasionally persists even after the liver transplantation, which may reduce the portal flow and thus threaten the patients' outcome. Therefore, pre- and peri-operative detection of portal steal phenomenon requiring radiological or surgical interruption is essential for the liver transplantation candidates as well as for the recipients.
Adult
;
Hepatitis B, Chronic/complications
;
Humans
;
Liver Cirrhosis/etiology/*therapy
;
*Liver Transplantation
;
Male
;
Mesenteric Veins/*ultrasonography
2.Undetectable, Small Uterine Cervical Tumors on MR Imaging: Comparison to Detectable Tumors.
Dongil CHOI ; Soo Ah KIM ; Bohyun KIM ; Jae Hoon LIM ; Jae Ho LEE ; Sang Yong SONG
Journal of the Korean Radiological Society 1997;37(2):321-326
PURPOSE: Small uterine cervical tumors are often undetected on MRI, and undetectable tumors are usually regarded as being in their early stages. The purpose of this study was to evaluate morphological factors determining MRI detectability of uterine cervical tumors by comparing detected and undetected tumors using high resolution MRI units. MATERIALS AND METHODS: Sixty-six surgically-proven uterine cervical cancer patients were included in this study. Using a GE Signa 1.5T magnet (GE, U.S.A.) axial T1-weighted MR images and axial, sagittal, and coronal T2-weighted fast spin echo MR images were obtained with a 5 mm thickness/2 mm gap and a 512x256 matrix size. The patients were divided into two groups, tumor-detected and tumor-undetected. Maximal tumor dimension, depth of stromal invasion, and horizontal tumor spread, measured during histopathological examinations, as well as pathological stages, were compared between the two groups. RESULTS: In the tumor-detected group, the pathological stages were IB1 in 25, IB2 in 3, IIA in 10, and IIB in 5 patients; in the tumor-undetected group, the stages were IA1 in 8, IA2 in 2, and IB1 in 13 patients. Maximal tumor dimension, depth of stromal invasion and horizontal tumor spread for tumor-detected and -undetected groups were 27.4 (10-60) mm vs. 10.4 (3-40) mm (p=0.077), 11.1 (3-20) mm vs. 2.3 (0-5) mm (p<0.001), and 26.6 (8-60) mm vs. 10.4 (3-40) mm (p=0.057), respectively. CONCLUSION: Of the criteria studied, depth of stromal invasion is the most important factor in determining tumor detectability on MRI. All tumors in which this depth was more than 5 mm were thus detected; which are undetected on high resolution MRI can be regarded as early-stage tumors (stage IB1).
Humans
;
Magnetic Resonance Imaging*
;
Uterine Cervical Neoplasms
3.LI-RADS Treatment Response versus Modified RECIST for Diagnosing Viable Hepatocellular Carcinoma after Locoregional Therapy: A Systematic Review and Meta-Analysis of Comparative Studies
Dong Hwan KIM ; Bohyun KIM ; Joon-Il CHOI ; Soon Nam OH ; Sung Eun RHA
Journal of the Korean Radiological Society 2022;83(2):331-343
Purpose:
To systematically compare the performance of liver imaging reporting and data system treatment response (LR-TR) with the modified Response Evaluation Criteria in Solid Tumors (mRECIST) for diagnosing viable hepatocellular carcinoma (HCC) treated with locoregional therapy (LRT).
Materials and Methods:
Original studies of intra-individual comparisons between the diagnostic performance of LR-TR and mRECIST using dynamic contrast-enhanced CT or MRI were searched in MEDLINE and EMBASE, up to August 25, 2021. The reference standard for tumor viability was surgical pathology. The meta-analytic pooled sensitivity and specificity of the viable category using each criterion were calculated using a bivariate random-effects model and compared using bivariate meta-regression.
Results:
For five eligible studies (430 patients with 631 treated observations), the pooled per-lesion sensitivities and specificities were 58% (95% confidence interval [CI], 45%–70%) and 93% (95% CI, 88%–96%) for the LR-TR viable category and 56% (95% CI, 42%–69%) and 86% (95% CI, 72%–94%) for the mRECIST viable category, respectively. The LR-TR viable category provided significantly higher pooled specificity (p < 0.01) than the mRECIST but comparable pooled sensitivity (p = 0.53).
Conclusion
The LR-TR algorithm demonstrated better specificity than mRECIST, without a significant difference in sensitivity for the diagnosis of pathologically viable HCC after LRT.
4.Malignant Tumors of the Appendix: Imaging Findings.
Hyo Keun LIM ; Seung Hoon KIM ; Kyung Ah KIM ; Yeon Ok LEE ; Sung Wook CHOO ; Bohyun KIM ; Jae Hoon LIM
Journal of the Korean Radiological Society 1998;38(5):889-895
Malignant tumors of the appendix are rare and are histologically similar to those arising elsewhere in theintestines. The frequency of specific tumor types and the clinical presentation of symptomatic tumors are,however, significantly different. Before surgery, correct diagnosis of a malignant appendiceal tumor is rare; mosttumors are diagnosed by a pathologist while examining an appendectomy specimen. With the advent of high resolutionimaging modalities (ultrasound and helical CT), malignant tumors of the appendix may be more accurately diagnosed;this report describes the imaging findings of malignant appendiceal tumors.
Appendectomy
;
Appendix*
;
Diagnosis
5.Anesthetic management with scalp nerve block and propofol/remifentanil infusion during awake craniotomy in an adolescent patient: A case report.
Bohyun SUNG ; Hee Soo KIM ; Jin Woo PARK ; Hyo Jin BYON ; Jin Tae KIM ; Chong Sung KIM
Korean Journal of Anesthesiology 2010;59(Suppl):S179-S182
Despite of various neurophysiologic monitoring methods under general anesthesia, functional mapping at awake state during brain surgery is helpful for conservation of speech and motor function. But, awake craniotomy in children or adolescents is worrisome considering their emotional friabilities. We present our experience on anesthetic management for awake craniotomy in an adolescent patient. The patient was 16 years old male who would undergo awake craniotomy for removal of brain tumor. Scalp nerve block was done with local anesthetics and we infused propofol and remifentanil with target controlled infusion. The patient endured well and was cooperative before scalp suture, but when surgeon sutured scalp, he complained of pain and was suddenly agitated. We decided change to general anesthesia. Neurosurgeon did full neurologic examinations and there was no neurologic deficit except facial palsy of right side. Facial palsy had improved with time.
Adolescent
;
Anesthesia, General
;
Anesthetics, Local
;
Brain
;
Brain Neoplasms
;
Child
;
Craniotomy
;
Dihydroergotamine
;
Facial Paralysis
;
Humans
;
Male
;
Nerve Block
;
Neurologic Examination
;
Neurologic Manifestations
;
Piperidines
;
Propofol
;
Scalp
;
Sutures
6.Diaphragmatic paralysis following alcohol celiac plexus neurolysis and a review of literature: A case report.
Jae Hun KIM ; Soo Young PARK ; Sahngun NAHM ; Bohyun SUNG ; Yong Chul KIM ; Sang Chul LEE
Anesthesia and Pain Medicine 2009;4(4):290-293
A 54-year-old man who had metastasis of gastric cancer was referred to pain clinic to control his severe epigastric pain.After the confirmation of the effect of the diagnostic celiac plexus block, c-arm-guided neurolysis of celiac plexus using alcohol was performed without any sensory or motor change.Five days after the chemical neurolysis, elevated hemidiaphragm and basal atelectasis of right lung were noted at routine chest X-ray follow-up without any respiratory symptoms such as dyspnea.There was no evidence of diaphragmatic metastasis. Two months after the neurolysis, the radiographic finding did not show any change.
Celiac Plexus
;
Follow-Up Studies
;
Humans
;
Lung
;
Middle Aged
;
Neoplasm Metastasis
;
Nerve Block
;
Pain Clinics
;
Pulmonary Atelectasis
;
Respiratory Paralysis
;
Stomach Neoplasms
;
Thorax
7.A case of levocetirizine-induced liver injury.
Moon Chan JUNG ; Ja Kyung KIM ; Jae Yeon CHO ; Jae Won SONG ; Bohyun LEE ; Ji Won PARK ; Jinwon SEO ; Sung Eun KIM
Clinical and Molecular Hepatology 2016;22(4):495-498
Levocetirizine is a second-generation nonsedative antihistaminic agent that has been demonstrated to be safe and effective for treating allergic disease. There was only one case report of levocetirizine-induced liver toxicity, but a liver biopsy was not performed. In this article, we present the first case of levocetirizine-induced liver injury with histologic findings. A 48-year-old man was hospitalized with jaundice and generalized pruritus that had developed after 2 months of therapy with levocetirizine for prurigo nodularis. Laboratory findings revealed acute hepatitis with cholestasis. A liver biopsy demonstrated portal inflammation and hepatitis with apoptotic hepatocytes. The patient fully recovered 3 weeks after withdrawing levocetirizine. Although levocetirizine is safe and effective, physicians should be aware of its potential hepatotoxicity.
Cetirizine/*adverse effects/therapeutic use
;
Chemical and Drug Induced Liver Injury/*diagnosis/pathology
;
Histamine H1 Antagonists, Non-Sedating/*adverse effects/therapeutic use
;
Humans
;
Hypersensitivity/drug therapy
;
Jaundice/etiology
;
Liver/pathology
;
Male
;
Middle Aged
;
Pruritus/etiology
8.Carcinoma of the Cervix: Usefulness of Dynamic and Contrast-Enhanced T1-weighted MR Imaging in Assessing theDepth of Stromal Invasion.
Dongil CHOI ; Bohyun KIM ; Eung yeup KIM ; Sung Ki CHO ; Jae Woong HWANG ; Moon Hae CHOI ; Sang Hee CHOI ; Seung Hoon KIM ; Chang Soo PARK ; Sang Yong SONG
Journal of the Korean Radiological Society 1998;39(5):983-989
PURPOSE: The purpose of this study was to evaluate the usefulness of contrast enhancement in assessing thedepth of stromal invasion in patients with uterine cervical tumors by comparing dynamic and late contrast-enhancedT1-weighted MR imaging with T2-weighted MR imaging. MATERIALS AND METHODS: Of 58 surgically proven uterinecervical cancer patients, 31 in whom tumors were seen on MRI were included in this study. Using a 1.5 T magnet,T2-weighted contrast-enhanced dynamic, and T1-weighted MR imaging were performed. In each MR imaging sequence,tumor visualization, margin delineation, enhancement pattern and depth of stromal invasion were evaluated onsagittal images and were correlated with pathological findings of resected uterus, focusing on the depth ofstromal invasion. RESULTS: Surgical FIGO stages were IB1 in 20 patients, IB2 in three, IIA in six, and IIB intwo. A tumor was detected in 29 (94%) patients on T2-weighted images, in 26 (84%) on dynamic contrast enhancedimages, and in 28 (90%) on contrast enhanced T1-weighted images. The tumor demonstrated a clear margin in 22 (71%)patients on late contrast-enhanced T1-weighted images, in 21 (68%) on dynamic images, and in 13 (42%) onT2-weighted images. Correlated with pathologic findings, the depth of stromal invasion was overestimated onT2-weighted images in eight (26%) patients, and on dynamic and late contrast-enhanced T1-weighted images in three(10%) and three (10%) respectively. CONCLUSION: Tumor margins are clearer and the extent of tumors may be moreaccurately evaluated on dynamic MR and late contrast-enhanced T1-weighted imaging. These sequences thas seem to beuseful, and superior to T2-weighted imaging, for assessing the depth of stromal invasion in patients with cervicalcarcinoma.
Cervix Uteri*
;
Female
;
Humans
;
Magnetic Resonance Imaging*
;
Uterus
9.High-level Expression of Interleukin-17 and C-reactive Protein Predicts Tumor Progression in Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization.
Myeong Jun SONG ; Sung Won LEE ; Eun Jee OH ; Bohyun JANG ; Jeong Won JANG ; Si Hyun BAE ; Jong Young CHOI ; Seung Kew YOON
Journal of Liver Cancer 2016;16(2):108-117
BACKGROUND/AIMS: Transarterial chemoembolization (TACE) is the standard locoregional treatment in patients with unresectable hepatocellular carcinoma (HCC). Angiogenesis and inflammation play important roles in tumor growth in HCC. In this study, we evaluated the associations between the levels of growth factors and inflammatory markers and clinical prognosis in patients with unresectable HCC treated with TACE. METHODS: The clinical outcomes of 58 HCC patients treated with TACE at the Catholic Medical Centers from January, 2012 to February 2015 were evaluated. Baseline levels of the growth factors vascular endothelial growth factor, fibroblast growth factor, platelet-derived growth factor, and hepatocyte growth factor and the inflammatory cytokines interleukin (IL)-17 and high sensitivity C-reactive protein (hs-CRP) were compared with the treatment outcomes. The primary endpoint was time to progression (TTP); the secondary endpoint was overall survival (OS). RESULTS: During the 20.8 months of follow-up, TTP was significantly delayed in patients with low levels of hs-CRP (≤0.15) and IL-17 (≤0.94) and a maximal tumor diameter ≤5 cm (P=0.010, P=0.015, and 0.048, respectively). Patients with HCC with low hs-CRP and IL-17 levels had a longer survival than that of those with high hs-CRP levels and IL-17 (35.1 vs. 22.5 months, P=0.000; 41 vs. 21.8 months, P=0.000, respectively). However, any baseline growth factors were not significantly correlated with TTP and OS. CONCLUSIONS: Elevated IL-17 and hs-CRP may be predictive of a poor outcome in patients with HCC treated with TACE. A better understanding of this relationship will require further investigation of the immune mechanisms underlying tumor progression.
C-Reactive Protein*
;
Carcinoma, Hepatocellular*
;
Cytokines
;
Fibroblast Growth Factors
;
Follow-Up Studies
;
Hepatocyte Growth Factor
;
Humans
;
Inflammation
;
Intercellular Signaling Peptides and Proteins
;
Interleukin-17*
;
Interleukins
;
Platelet-Derived Growth Factor
;
Prognosis
;
Vascular Endothelial Growth Factor A
10.Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases.
Bohyun JANG ; Ji Won HAN ; Pil Soo SUNG ; Jeong Won JANG ; Si Hyun BAE ; Jong Young CHOI ; Young I CHO ; Seung Kew YOON
Journal of Korean Medical Science 2016;31(12):1943-1948
Since liver function is changed by chronic liver diseases, chronic liver disease can lead to different hemorheological alterations during the course of the progression. This study aims to compare alterations in whole blood viscosity in patients with chronic liver disease, focusing on the gender effect. Chronic liver diseases were classified into three categories by patient’s history, serologic markers, and radiologic findings: nonalcoholic fatty liver disease (NAFLD) (n = 63), chronic viral hepatitis B and C (n = 50), and liver cirrhosis (LC) (n = 35). Whole blood viscosity was measured by automated scanning capillary tube viscometer, while liver stiffness was measured by transient elastography using FibroScan®. Both systolic and diastolic whole blood viscosities were significantly lower in patients with LC than NAFLD and chronic viral hepatitis (P < 0.001) in male patients, but not in female patients. In correlation analysis, there were inverse relationships between both systolic and diastolic whole blood viscosity and liver stiffness (systolic: r = −0.25, diastolic: r = −0.22). Whole blood viscosity was significantly lower in male patients with LC than NAFLD or chronic viral hepatitis. Our data suggest that whole blood viscosity test can become a useful tool for classifying chronic liver disease and determining the prognosis for different types of chronic liver diseases.
Blood Viscosity
;
Capillaries
;
Elasticity Imaging Techniques
;
Female
;
Hemorheology
;
Hepatitis
;
Hepatitis B
;
Humans
;
Liver Cirrhosis
;
Liver Diseases*
;
Liver*
;
Male
;
Non-alcoholic Fatty Liver Disease
;
Prognosis